| 000 | 01125 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513210449.0 | ||
| 264 | 0 | _c20000427 | |
| 008 | 200004s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM200004273421714 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAggarwal, A | |
| 245 | 0 | 0 |
_aPrevention of sudden death in patients with coronary artery disease. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cApr 2000 |
||
| 300 |
_a1291; author reply 1291-2 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCardiac Pacing, Artificial |
| 650 | 0 | 4 |
_aCoronary Disease _xcomplications |
| 650 | 0 | 4 |
_aDeath, Sudden, Cardiac _xprevention & control |
| 650 | 0 | 4 | _aDefibrillators, Implantable |
| 650 | 0 | 4 | _aElectrophysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPropafenone _xadverse effects |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 342 _gno. 17 _gp. 1291; author reply 1291-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM200004273421714 _zAvailable from publisher's website |
| 999 |
_c10739680 _d10739680 |
||